Request Your Free eGuide Now:

"Scaling to New Heights: Robust Scale Up from Shake Flask to Commercial AAV Manufacturing for All Patient Populations"

Download This Insightful Guide Today!

Genetic therapies utilizing adeno-associated viral (AAV) vectors have evolved in recent years from proof of concept to successful treatment options for patients with previously difficult to treat diseases. However, to be successful for multiple and larger patient populations, these groundbreaking therapies must overcome the critical challenge of manufacturing at a scale that meets the growing global need.  

Access this valuable resource to discover how developers working on larger indications or patient populations can efficiently manufacture at necessary scales while still providing high-quality, safe, and effective drug products. You’ll learn about: 

• How to recognize the capacity and technical gaps in the current market  
• Solutions for streamlining the AAV production process  
• Ways to effectively bridge the gap between small-scale laboratory experiments and commercial-scale manufacturing for accelerating gene therapy programs to reach patients faster 
• Utilizing the same process, cell line, facility, and analytics to help reduce any need for bridging studies as manufacturing moves through preclinical, clinical, and commercial development planning 
• And more 

Offered Free by: Forge Biologics
See All Resources from: Forge Biologics